VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
OHR/AVR118
Phase 2
Small molecule
O
Ohr Pharmaceutical Inc.
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Anorexia
1 trial
Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia
Unknown status
·
O
Ohr Pharmaceutical Inc.
·
Phase 2
·
NCT01206335
·
20 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for OHR/AVR118. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
OHR/AVR118 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for OHR/AVR118. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Ohr Pharmaceutical Inc. company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 2
[1]
Company
O
Ohr Pharmaceutical Inc.
Related News